Wire Stories

Ubiquitome gets FDA authorization with Yale SARS-CoV-2 self-collection tests

NIH RADx winner�s next gen Liberty16 Pro gets EUA AUCKLAND, New Zealand--(BUSINESS WIRE)--#COVIDCATCHER--Ubiquitome�s next generation real time PCR device system,…

2 years ago

Company envisions up to 1,000 jobs in Isahaya City as other sites near full capacity KYOTO, JAPAN--(BUSINESS WIRE)--Kyocera Corporation (President:…

2 years ago

Tocilizumab is an important anti-rheumatic agent used in the treatment of adult patients with moderate to severe active rheumatoid arthritis…

2 years ago

Introducing THE BRIJ – A World of Arts and Culture

Serendipity Arts announces THE BRIJ, a futuristic arts and culture centre in the National Capital Region that will host multiple…

2 years ago

Movers Buddy Reports Affordable Suburbs To Move To If You Want To Save On Rent In Melbourne And Sydney

MELBOURNE, Australia--(BUSINESS WIRE)--As rents continue to soar, Australian families are struggling more than ever before to find affordable housing. When…

2 years ago

Dongying seeks trade opportunities in overseas markets

DONGYING, China--(BUSINESS WIRE)--Dongying, a city in East China�s Shandong province, has been helping local enterprises expand in international markets as…

2 years ago

A Third of Businesses Predict the Current Inflationary Environment to Last More Than Two Years – Taulia

SAN FRANCISCO--(BUSINESS WIRE)--A third of global businesses predict the current inflationary environment to continue for more than two years, according…

2 years ago

Daiichi Sankyo and AstraZeneca�s ENHERTU is the first HER2 directed therapy to demonstrate a significant survival benefit versus chemotherapy in…

2 years ago

First HER2 directed medicine to be approved for gastric cancer in the EU in more than a decade Based on…

2 years ago

Mitsubishi Electric to Delist Shares on London Stock Exchange

TOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation (TOKYO:6503) announced today that it has decided to apply for the delisting of its shares of…

2 years ago
Show more Posts
Show previous Posts